Michael Banks, MD, discusses the risk for cirrhosis regression and liver cancer in patients with HCV-related cirrhosis who have already achieved SVR via DAA treatment.
In this video, Vikas Majithia, MD, talks about how the COVID-19 pandemic has affected the fellows he oversees and how digital video platforms have allowed for consistent education.
